Hilzinger Kurt J's Form 4 filing
Outlook Therapeutics, Inc. (OTLK) · filed Oct 3, 2022
- Accession no.
- 0001209191-22-051912
- Filed
- Oct 3, 2022
- Trade date
- Sep 29-Oct 3, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $110.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hilzinger Kurt JCIK 0001191504 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 29, 2022 | Common Stock | PPurchaseAcquired | +13,800 | $1.19 | +$16,422 | 286,917 | Direct | |
| Sep 30, 2022 | Common Stock | PPurchaseAcquired | +33,199 | $1.26 | +$41,830.74 | 320,116 | Direct | |
| Oct 3, 2022 | Common Stock | PPurchaseAcquired | +41,798 | $1.25 | +$52,247.5 | 361,914 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.